Is TB-500 Legal in Arizona? How to Access It Legally

HealthRX.com

TB-500 has no approved or listed legal route in Arizona

Print or save as PDF

See the public record for TB-500

  • What it is / a synthetic seven-amino-acid fragment (residues 17 to 23) of thymosin beta-4 [1]
  • FDA approval / none, in the US or in any market FDA checked [1]
  • Advisory committee / voted July 23, 2026 to recommend adding it to the bulks list; advice only [7][5]
  • Draft HHS policy / names TB-500 acetate for injection; applies only when its conditions are met [5][6]
  • Human data / FDA found no article in which TB-500 was given to a human [1]
  • Sport / WADA prohibits thymosin beta-4 and derivatives such as TB-500 at all times [8]

What it is and where it stands federally

TB-500 is a synthetic seven-amino-acid fragment (residues 17 to 23) of the 43-amino-acid protein thymosin beta-4, N-acetylated, with a molecular weight of about 889 g/mol [1]. It is not an FDA-approved drug: FDA's July 2026 review found no USP or National Formulary monograph, no FDA-approved drug containing it, and no approved product in Canada, Australia, the UK, several EU countries or through the European Medicines Agency [1].

A state-licensed pharmacy may compound with a bulk substance only if it complies with a USP or NF monograph, is a component of an FDA-approved drug, or appears on FDA's bulks list [4]. TB-500 meets none of these and is not on the bulks list. It also appears in none of the three categories on FDA's interim-policy list for state-licensed pharmacies (updated May 14, 2026) or on FDA's list for outsourcing facilities (updated March 21, 2025), so FDA's category 1 policy does not cover it [2][3][4]. It appears on FDA's safety-risk page only in the 'nominated but withdrawn' table, and removal from category 2 was not a safety finding [9].

FDA's advisory committee voted on July 23, 2026 to recommend adding TB-500 to the bulks list, against FDA staff's recommendation [7][1]. That vote is non-binding, and listing requires formal rulemaking [7][5].

The draft HHS policy

HHS filed a draft enforcement-discretion policy on October 28, 2026 (Federal Register document 2026-22192) naming TB-500 with five other peptides. It covers the acetate form given by subcutaneous or intramuscular injection [5][6]. HHS says it 'does not intend to take enforcement action' against a state-licensed pharmacy, federal facility or licensed physician compounding with it where the conditions are met. Examples are a single active ingredient, a patient-specific prescription, an FDA-registered manufacturer supplying the substance with a certificate of analysis, and the label 'This is a compounded drug product. Not for resale.' [5][6]

The notice is a draft, with comments due two weeks after publication. It says it does not establish any rights and is not binding on HHS or the public, and HHS may revisit it, for example if a safety signal or product quality issue arises [5]. Compounded drugs are not FDA-approved: FDA does not review their safety, effectiveness or quality before marketing [5].

Arizona

Federal findings do not establish whether Arizona law permits TB-500. What the federal record does show is that FDA found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1].

Human data and sport

FDA found no article in which TB-500 was given to a human, no approved dose and no human dosing study, and safety in humans is unknown [1]. WADA's Prohibited List names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3, prohibited at all times in and out of competition, on the 2026 and 2027 Lists [8][10].

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. According to the article, when are comments on the draft HHS notice due?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Is TB-500 legal in Arizona?
Federal findings do not establish whether Arizona law permits it. TB-500 is not an FDA-approved drug [1]. A draft HHS policy describes limited circumstances for compounding TB-500 acetate for injection with a patient-specific prescription, but it is not an approval or a legal right to obtain the product [5][6].
Can an Arizona pharmacy fill a TB-500 prescription?
Not under the standard compounding rules, which TB-500 does not meet [4]. FDA found no pharmacy marketing a compounded TB-500 product [1]. The draft HHS policy would, if conditions such as a single active ingredient, a patient-specific prescription and an FDA-registered manufacturer with a certificate of analysis are met, describe non-enforcement, not approval [5][6].
Did the advisory committee vote make TB-500 legal to compound?
No. The committee voted on July 23, 2026 to recommend adding TB-500 to the bulks list, against FDA staff's recommendation. The vote is non-binding advice, TB-500 is not on the list, and listing requires formal rulemaking [7][1][5].
Has TB-500 been tested in humans?
FDA found no article in which TB-500 was given to a human, and none of the three papers the nominator cited involved TB-500 in humans [1]. There is no approved dose and no human dosing study [1].
Show all 10 referencesHide references
Evidence overview for Is TB-500 Legal in Arizona? How to Access It Legally